Gattex is an injection of a protein involved in the rehabilitation of the intestinal lining. Of the 88 patients studied, 13 had complete independence from parenteral support after using the treatment. Others had support volumes reduced or gained days off parenteral support.
Company representatives will present the results at the American College of Gastroenterology’s Annual Scientific Meeting and Postgraduate Course in San Diego this month.
More Articles on Gastroenterology:
RedHill Biopharma Seeks Patients for Phase III Crohn’s Disease Treatment Drug Trial
Kanawha Valley Gastroenterology Associates Selects Benchmark Systems EHR
Dr. Gurpreet Singh Joins Woodland Healthcare in California
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
